Vanguard Capital Wealth Advisors’s Nautilus Biotechnolgy NAUT Stock Holding History
Bought
Maintained
Sold
Other funds holding NAUT
PA
ACM
CM
CFM
CA
Vanguard Capital Wealth Advisors's NAUT Position: Q2 2026 in Review
Vanguard Capital Wealth Advisors held its Nautilus Biotechnolgy (NAUT) position steady in Q2 2026 at 13,000 shares worth $24.3K. The position accounts for 0.02% of the portfolio, ranked #130.
Vanguard Capital Wealth Advisors first reported a position in NAUT in Q4 2021 and has held it in 19 quarters since. The position peaked at $235K in Q4 2021. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.
- Vanguard Capital Wealth Advisors held 13,000 shares of Nautilus Biotechnolgy worth $24.3K as of Q2 2026.
- Vanguard Capital Wealth Advisors left its Nautilus Biotechnolgy share count unchanged in Q2 2026.
- Nautilus Biotechnolgy made up 0.02% of Vanguard Capital Wealth Advisors's portfolio in Q2 2026, its #130 holding.
- Vanguard Capital Wealth Advisors first reported a position in Nautilus Biotechnolgy in Q4 2021 and has held it in 19 quarters since.
- Vanguard Capital Wealth Advisors's Nautilus Biotechnolgy position peaked at $235K in Q4 2021.
- 93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.
Based on Vanguard Capital Wealth Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.